Hemida, Reda <br/><br/>
Second Uterine Curettage and the Number of Chemotherapy Courses in Postmolar Gestational Trophoblastic Neoplasia: A Randomized Controlled Trial.  [electronic resource] 

 -  Obstetrics and gynecology  05 2019 
 - 1024-1031 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1873-233X 
<br/><br/><label>Standard No.: </label>10.1097/AOG.0000000000003232  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Combined Modality Therapy<br/>Curettage<br/>Female<br/>Gestational Trophoblastic Disease--drug therapy<br/>Humans<br/>Methotrexate--administration & dosage<br/>Pregnancy<br/>Treatment Outcome<br/>Uterine Neoplasms--drug therapy